JPRN-UMIN000032333已完成未知
A using test for four continuous weeks of SC1722 against babies - A using test for four continuous weeks of SC1722 against babies
Inforward, inc EBISU skin research center0 个研究点目标入组 60 人开始时间: 2019年5月10日最近更新:
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 发起方
- 入组人数
- 60
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 28days-old 至 365days-old（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •1)Premature babies. 2)Subjects with birth weight >2,500g. 3)Subjects who have severe eczema infantile. 4)Subjects who have skin symptom such as atopic dermatitis. 5)Subjects who have trauma on the part that uses the test sample. 6)Subjects who have possibility to take a lot of sunlight. 7)Subjects who are participating in clinical tests and use tests that apply cosmetic, quasi-drugs and others. 8)Subjects who have allergic symptoms against external medicine, cosmetic, quasi-drugs and others in the past. 9)Subjects who have previous and/or current medical history of serious disease in liver, kidney, myocardial infarction. 10)Subject who are going to hospital and being accepted medical treatment due to disease. 11)Subjects who have their family that are working for cosmetic companies and pharmaceutical companies. 12)Others who have been determined ineligible by investigator.
研究者
相似试验
已完成
不适用
A using test for four continuous weeks of C-271 in babiesot applicableJPRN-UMIN000038263Inforward, inc EBISU skin research center60
招募中
不适用
Testing an increased visit interval scHeme UsIng web-based Self-evaluation (THUIS-study)JIAJuvenile Idiopathic ArthritisNL-OMON51944niversitair Medisch Centrum Utrecht85
招募中
1 期
VACCINE EFFECTIVENESS OF 20-VALENT PNEUMOCOCCAL CONJUGATE VACCINE AGAINST VACCINE-TYPE CAP USING A TEST-NEGATIVE DESIGVACCINE-TYPE RADIOLOGICALLY-CONFIRMED COMMUNITY-ACQUIRED PNEUMONIAMedDRA version: 20.1Level: LLTClassification code: 10010120Term: Community acquired pneumonia Class: 10021881CTIS2023-507293-40-00Pfizer Inc.12,500
招募中
4 期
Study to assess safety, tolerability and effectiveness in patients with severe dementia exposed to exeloCTRI/2018/02/011948ovartis India Limited
已完成
不适用
4-MONTH MONITORING STUDY TO EVALUATE THE RATE OF NASAL POLYPOSIS IN SUBJECTS WHICH IMPROVED WITH UP TO 4 MONTHS OF TREATMENT WITH MOMETHASONE FUROATE IN NASAL OR PLACEBO AEROSOL IN STUDY P01925-J33J33PER-034-02SCHERING PLOUGH RESEARCH INSTITUTE,